Quick Answer
HAEMONETICS CORP reported Net Income of $167.68 million for fiscal year 2025.
HAEMONETICS CORP Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $167.68M | +42.6% |
| 2024 | $117.56M | +1.9% |
| 2023 | $115.40M | +166.1% |
| 2022 | $43.38M | -45.4% |
| 2021 | $79.47M | +3.8% |
| 2020 | $76.53M | +39.1% |
| 2019 | $55.02M | +20.7% |
| 2018 | $45.57M | +273.5% |
| 2017 | -$26.27M | +52.7% |
| 2016 | -$55.58M | -428.9% |
| 2015 | $16.90M | -51.9% |
| 2014 | $35.15M | -9.4% |
| 2013 | $38.80M | -42.0% |
| 2012 | $66.89M | -16.4% |
| 2011 | $79.98M | +37.0% |
| 2010 | $58.37M | -1.6% |
| 2009 | $59.30M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | $44.74M | +19.3% | +15.7% |
| September 30, 2025 | $38.68M | +14.3% | +13.7% |
| June 30, 2025 | $34.03M | -11.3% | -9.2% |
| December 31, 2024 | $37.49M | +20.0% | +10.8% |
| September 30, 2024 | $33.83M | +35.8% | -11.8% |
| June 30, 2024 | $38.37M | -6.5% | +22.8% |
| December 31, 2023 | $31.24M | -5.2% | +25.4% |
| September 30, 2023 | $24.91M | -25.0% | -39.3% |
- HAEMONETICS CORP showed an increase of +42.6% in Net Income compared to the prior fiscal year.
- Over the 2009–2025 period, HAEMONETICS CORP’s net income has grown by 182.7% (from $59.30 million to $167.68 million).
- The most recent figure is from HAEMONETICS CORP’s fiscal year 2024 report (Form 10-K), filed with the SEC on May 21, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: